CSIMarket
 

La Jolla Pharmaceutical Company  (LJPC)
Other Ticker:  
 

La Jolla Pharmaceutical's Working Capital Per Sales

LJPC's Working Capital and Revenue growth



LJPC Working Capital Per Revenue (Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
Y / Y Working Capital Change 1.29 % 9.63 % 147.39 % 105.01 % -19.67 %
Y / Y Revenue Change -34.35 % -69.46 % 11.5 % 46.76 % 176.64 %
Working Capital Per Revenue 1.11 0.99 0.67 0.56 0.5
Total Ranking # 3317 # 3317 # 1648 # 1791 # 1298
Seq. Working Capital Change 6.39 % -22.1 % 20.15 % 1.72 % 15.16 %
Seq. Revenue Change 1.13 % -14.62 % -8.29 % -17.09 % -52.96 %





Comment on LJPC's Working Capital Per Revenue in the second quarter 2022
La Jolla Pharmaceutical's Working Capital Per Revenue sequentially grew to 1.11 during the Q2 2022, below the La Jolla Pharmaceutical average. Due to increase of revenue in the Q2 2022 year on year by -34.35%.

Within Healthcare sector 64 other companies have achieved lower Working Capital Per Revenue during the Q2 2022. While Working Capital Per Revenue remained unchanged in the Q2 2022 relative to the prior quarter at no. 3317.
Working Capital Per Revenue Ranking
Within: No.
Industry # 5
Sector # 65
S&P 500 # 3317


Working Capital Per Revenue Statistics
High Average Low
12.84
3.22
0.5
(Mar 31 2019)   (Jun 30 2021)



Financial Statements
La Jolla Pharmaceutical's Working Capital $ 50 Millions Visit LJPC's Balance sheet
La Jolla Pharmaceutical's Revenues $ 11 Millions Visit LJPC's Income Statement
Where are LJPC's Sales coming from? Visit LJPC's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Jun 30 2022, within Healthcare Sector Working Capital Per Revenue
Nuwellis Inc   2.97 
Clearpoint Neuro Inc   2.92 
Molecular Templates inc   2.89 
Castle Biosciences Inc   2.89 
Sonendo Inc   2.88 
Neurometrix Inc   2.81 
Avita Medical Inc   2.80 
Quotient Limited  2.77 
Macrogenics Inc   2.76 
Neuropace Inc   2.72 
Esperion Therapeutics inc   2.70 
Fortress Biotech Inc   2.66 
Deciphera Pharmaceuticals Inc   2.65 
Blueprint Medicines Corporation  2.58 
Twist Bioscience Corporation  2.58 
Guardant Health Inc   2.55 
Ginkgo Bioworks Holdings Inc   2.52 
Voyager Therapeutics Inc   2.49 
Qualigen Therapeutics Inc   2.49 
Nanostring Technologies Inc   2.48 
Elicio Therapeutics Inc   2.44 
Cryoport inc   2.42 
Viewray Inc   2.42 
Global Blood Therapeutics Inc.  2.42 
Dariohealth Corp   2.40 
Wave Life Sciences Ltd   2.40 
Sarepta Therapeutics Inc   2.38 
Avinger Inc   2.35 
Ionis Pharmaceuticals Inc  2.34 
Intelgenx Technologies Corp   2.33 
Date modified: 2023-03-22T19:11:53+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com